Meningioma frequently occurs in WS patients (Tsurubuchi et al., 2008; Huang et al., 2018; Pattankar et al., 2020), and this is likely a consequence of a reduced WRN expression due to the elevated methylation of the WRN promoter (Li et al., 2015). The gene discussed is WRN; the disease is meningioma.